Revelation Biosciences Warrant
REVBW
13 hedge funds and large institutions have $18.6K invested in Revelation Biosciences Warrant in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 5 reducing their positions, and 2 closing their positions.
7% less funds holding
Funds holding: 14 → 13 (-1)
7.3% less ownership
Funds ownership: 82.93% → 75.62% (-7.3%)
28% less capital invested
Capital invested by funds: $25.9K → $18.6K (-$7.36K)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$221 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PFM
Privium Fund Management
Amsterdam,
Netherlands
|
-$752 |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$700 |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$292 |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$230 |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$29 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LA
1
Linden Advisors
New York
| $5.07K | – | – | – |
|
|
YCM
2
Yakira Capital Management
Westport,
Connecticut
| $3.7K | – | – | – |
|
3
Walleye Capital
New York
| $2.81K | – | – | – |
|
|
PVI
4
Pine Valley Investments
Marlton,
New Jersey
| $2.13K | – | – | – |
|
5
Walleye Trading
New York
| $1.57K | – | – | – |
|
|
CAC
6
Cowen and Company
New York
| $1.5K | -$1 | -100 | -0.1% |
|
7
Jane Street
New York
| $750 | – | – | – |
|
|
8
Citadel Advisors
Miami,
Florida
| $423 | -$230 | -16,453 | -36% |
|
|
WAM
9
Wolverine Asset Management
Chicago,
Illinois
| $333 | -$700 | -50,000 | -69% |
|
|
TSS
10
Two Sigma Securities
New York
| $237 | +$221 | +15,814 | New |
|
|
11
UBS Group
Zurich,
Switzerland
| $40 | -$29 | -2,047 | -43% |
|
|
PIS
12
POM Investment Strategies
Raleigh,
North Carolina
| $15 | – | – | – |
|
|
CS
13
Clear Street
New York
| $2 | -$1 | -100 | -50% |
|
|
PFM
14
Privium Fund Management
Amsterdam,
Netherlands
| – | -$752 | -44,000 | Closed |
|
|
15
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$292 | -14,575 | Closed |
|
REVBW Hedge Fund Activity: Q3 2024 in Review
13 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences Warrant (REVBW) for Q3 2024, worth a combined $18.6K — down 28% from $25.9K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of REVBW and 1 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 0 added.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $221. The largest seller was Privium Fund Management, exiting entirely with an estimated $752 sold.
- 13 institutional investors held Revelation Biosciences Warrant (REVBW) as of Q3 2024, down from 14 in Q2 2024.
- Funds reported $18.6K of Revelation Biosciences Warrant stock for Q3 2024, down 28% quarter-over-quarter.
- 1 fund opened new Revelation Biosciences Warrant positions in Q3 2024 and 2 closed out, a net change of -1 holder.
- The largest Revelation Biosciences Warrant buyer in Q3 2024 was Two Sigma Securities, an estimated $221 added.
- The largest Revelation Biosciences Warrant seller in Q3 2024 was Privium Fund Management, an estimated $752 sold.
Based on aggregated 13F filings for Q3 2024.